Azenta Share Price (NASDAQ: AZTA)

$29.83

▲

-0.46

(-1.52%)

Live

Last updated on August 20, 2025 at 11:43 PM IST

$₹

Check the interactive Azenta Stock chart to analyse performance

Azenta stock performance

as on August 20, 2025 at 11:43 PM IST

Today's Low:$29.43
Today's High:$29.83
$29.83
1.34%
Downside
Day's Volatility :1.34%
Upside
0.0%
52 Weeks Low:$23.91
52 Weeks High:$55.64
$29.83
19.85%
Downside
52 Weeks Volatility :57.02%
Upside
46.38%

Azenta Stock Returns

Period	Azenta Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	10.33%	1.5%	0.0%
6 Months	-33.25%	-7.1%	0.0%
1 Year	-39.24%	-11.4%	0.0%
3 Years	-44.78%	2.9%	-9.6%

Azenta Inc Key Stats

Check Azenta key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$30.29
Open	$30.77
Today's High	$29.91
Today's Low	$29.43
Market Capitalization	$1.4B
Today's Volume	$378.8K
52 Week High	$55.635
52 Week Low	$23.91
Revenue TTM	$668.8M
EBITDA	$34.0M
Earnings Per Share (EPS)	$-3.25
Profit Margin	-16.68%
Quarterly Earnings Growth YOY	87.78%
Return On Equity TTM	-9.15%

Stock Returns calculator for Azenta Stock including INR - Dollar returns

The Azenta stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Azenta investment value today

Current value as on today

₹63,668

Returns

₹36,332

(-36.33%)

Returns from Azenta Stock

₹40,220 (-40.22%)

Dollar Returns*

₹3,889 (+3.89%)

Indian investors sentiment towards Azenta Stock

88%

Period: Jul 20, 2025 to Aug 19, 2025. Change in 30 Days versus previous period

Search interest for Azenta Stock from India on INDmoney has increased by 88% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Azenta Inc

Name
Holdings %
Name
Holdings %
BlackRock Inc
11.80%
Politan Capital Management LP
10.08%
Vanguard Group Inc
9.97%
Dimensional Fund Advisors, Inc.
5.94%
Kayne Anderson Rudnick Investment Management LLC
4.66%
Conestoga Capital Advisors, LLC
4.19%

Analyst Recommendation on Azenta Stock

Rating

Trend

Buy

53%Buy

46%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Azenta(by analysts ranked 0 to 5 stars)

Azenta Share Price Target

What analysts predicted

Upside of 10.63%

Target:

$33.00

Current:

$29.83

Azenta share price target is $33.00, a slight Upside of 10.63% compared to current price of $29.83 as per analysts' prediction.

Azenta Stock Insights

Price Movement
In the last 7 days, AZTA stock has moved down by -5.5%
Increasing Revenue
Revenue is up for the last 2 quarters, 143.41M → 143.94M (in $), with an average increase of 0.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, -4.98M → -52.80M (in $), with an average decrease of 133.8% per quarter
AZTA vs RMD (1 yr)
In the last 1 year, Resmed Inc. has given 28.1% return, outperforming this stock by 67.3%
AZTA vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 22.4% return, outperforming this stock by 69.8%
Price to Sales
ForAZTA every $1 of sales, investors are willing to pay $2.1, whereas for Resmed Inc., the investors are paying $8.1 for every $1 of sales.

Azenta Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$781.9M	↑ 23.8%
Net Income	$9.9M	↓ 91.52%
Net Profit Margin	1.26%	↓ 17.2%

	FY20	Y/Y Change
Revenue	$897.3M	↑ 14.76%
Net Income	$64.9M	↑ 555.74%
Net Profit Margin	7.23%	↑ 5.97%

	FY21	Y/Y Change
Revenue	$513.7M	↓ 42.75%
Net Income	$-28.9M	↓ 144.51%
Net Profit Margin	-5.62%	↓ 12.85%

	FY22	Y/Y Change
Revenue	$555.5M	↑ 8.14%
Net Income	$-11.3M	↓ 60.91%
Net Profit Margin	-2.03%	↑ 3.59%

	FY23	Y/Y Change
Revenue	$665.1M	↑ 19.73%
Net Income	$-14.3M	↑ 26.32%
Net Profit Margin	-2.14%	↓ 0.11%

	FY24	Y/Y Change
Revenue	$656.3M	↓ 1.32%
Net Income	$-164.2M	↑ 1051.5%
Net Profit Margin	-25.01%	↓ 22.87%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$159.1M	↑ 3.12%
Net Income	$-136.9M	↑ 770.52%
Net Profit Margin	-86.02%	↓ 75.83%

	Q2 FY24	Q/Q Change
Revenue	$172.8M	↑ 8.59%
Net Income	$-6.6M	↓ 95.19%
Net Profit Margin	-3.81%	↑ 82.21%

	Q3 FY24	Q/Q Change
Revenue	$170.1M	↓ 1.59%
Net Income	$-5.0M	↓ 24.28%
Net Profit Margin	-2.93%	↑ 0.88%

	Q4 FY24	Q/Q Change
Revenue	$147.5M	↓ 13.26%
Net Income	$-13.3M	↑ 167.66%
Net Profit Margin	-9.04%	↓ 6.11%

	Q1 FY25	Q/Q Change
Revenue	$143.4M	↓ 2.77%
Net Income	$-40.5M	↑ 203.27%
Net Profit Margin	-28.21%	↓ 19.17%

	Q2 FY25	Q/Q Change
Revenue	$143.9M	↑ 0.37%
Net Income	$-52.8M	↑ 30.53%
Net Profit Margin	-36.69%	↓ 8.48%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$316.8M	↑ 28.72%

	FY20	Y/Y Change
Profit	$380.0M	↑ 19.97%

	FY21	Y/Y Change
Profit	$243.8M	↓ 35.84%

	FY22	Y/Y Change
Profit	$255.6M	↑ 4.83%

	FY23	Y/Y Change
Profit	$263.1M	↑ 2.96%

	FY24	Y/Y Change
Profit	$263.4M	↑ 0.09%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$56.7M	↓ 7.77%

	Q2 FY24	Q/Q Change
Profit	$69.1M	↑ 21.73%

	Q3 FY24	Q/Q Change
Profit	$69.4M	↑ 0.52%

	Q4 FY24	Q/Q Change
Profit	$68.7M	↓ 1.07%

	Q1 FY25	Q/Q Change
Profit	$65.9M	↓ 4.06%

	Q2 FY25	Q/Q Change
Profit	$67.8M	↑ 2.84%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$90.9M	↑ 22.89%
Investing Cash Flow	$211.3M	↓ 242.33%
Financing Cash Flow	$-191.2M	↓ 212.26%

	FY20	Y/Y Change
Operating Cash Flow	$37.9M	↓ 58.34%
Investing Cash Flow	$-22.7M	↓ 110.76%
Financing Cash Flow	$-27.0M	↓ 85.86%

	FY21	Y/Y Change
Operating Cash Flow	$149.9M	↑ 295.76%
Investing Cash Flow	$-146.3M	↑ 543.52%
Financing Cash Flow	$-25.9M	↓ 4.13%

	FY22	Y/Y Change
Operating Cash Flow	$-466.0M	↓ 410.99%
Investing Cash Flow	$1.5B	↓ 1101.43%
Financing Cash Flow	$-62.8M	↑ 142.27%

	FY23	Y/Y Change
Operating Cash Flow	$17.5M	↓ 103.75%
Investing Cash Flow	$431.4M	↓ 70.57%
Financing Cash Flow	$-844.1M	↑ 1244.89%

	FY24	Y/Y Change
Operating Cash Flow	$50.3M	↑ 187.53%
Investing Cash Flow	$224.7M	↓ 47.9%
Financing Cash Flow	$-659.2M	↓ 21.9%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$8.4M	↓ 68.39%
Investing Cash Flow	$-270.6M	↓ 375.02%
Financing Cash Flow	$-74.1M	↓ 34.54%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$1.8M	↓ 78.57%
Investing Cash Flow	$201.6M	↓ 174.51%
Financing Cash Flow	$-224.4M	↑ 203.02%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$13.7M	↑ 665.55%
Investing Cash Flow	$195.3M	↓ 3.12%
Financing Cash Flow	$-247.5M	↑ 10.29%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$30.6M	↑ 123.38%
Investing Cash Flow	$76.3M	↓ 60.96%
Financing Cash Flow	$-5.1M	↓ 97.93%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$13.6M	↓ 55.68%
Investing Cash Flow	$-137.8M	↓ 280.76%
Financing Cash Flow	$-5.2M	↑ 0.55%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$25.8M	↑ 90.16%
Investing Cash Flow	$-29.7M	↓ 78.45%
Financing Cash Flow	$-128.0K	↓ 97.52%

Azenta Technicals Summary

Sell

Neutral

Buy

Azenta is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Azenta Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Azenta Inc	-3.19%	-33.25%	-39.24%	-44.78%	-69.7%
Intuitive Surgical, Inc.	-7.15%	-21.24%	-0.83%	119.28%	107.19%
Alcon Ag	3.44%	0.66%	-6.58%	32.7%	53.82%
West Pharmaceutical Services Inc	17.56%	21.97%	-17.43%	-20.71%	-9.03%
Resmed Inc.	9.5%	21.9%	28.11%	24.64%	59.37%
Becton, Dickinson And Company	12.9%	-13.01%	-15.67%	-24.08%	-23.19%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Azenta Inc	1.57	NA	NA	0.51	-0.09	-0.02	NA	36.55
Intuitive Surgical, Inc.	67.22	67.22	3.53	8.12	0.16	0.09	NA	49.79
Alcon Ag	39.17	39.17	2.4	3.11	0.05	0.03	0.0	44.39
West Pharmaceutical Services Inc	36.45	36.45	3.51	6.76	0.18	0.11	0.0	40.74
Resmed Inc.	30.12	30.12	1.93	9.5	0.26	0.14	0.01	40.77
Becton, Dickinson And Company	35.65	35.65	0.98	14.35	0.06	0.04	0.02	88.87

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Azenta Inc	Buy	$1.4B	-69.7%	1.57	-16.68%
Intuitive Surgical, Inc.	Buy	$172.5B	107.19%	67.22	28.51%
Alcon Ag	Buy	$43.8B	53.82%	39.17	11.28%
West Pharmaceutical Services Inc	Buy	$17.5B	-9.03%	36.45	16.48%
Resmed Inc.	Buy	$41.9B	59.37%	30.12	27.22%
Becton, Dickinson And Company	Buy	$55.9B	-23.19%	35.65	7.41%

Azenta Dividend announcements

Azenta Dividends December, 2021
In the quarter ending December,2021. Azenta has declared dividend of $0.10

About Azenta Inc

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, synthesis editing, and related services. The B Medical Systems segment manufactures and distributes temperature-controlled storage and transportation solutions to governments, health institutions, and non-government organizations. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Organization	Azenta
Employees	3000
CEO	Mr. Luc Provost
Industry	Technology

Key Management of Azenta Inc

Name	Title
Mr. John P. Marotta	President, CEO & Director
Dr. Ginger Zhou Ph.D.	Senior VP & President of GENEWIZ
Mr. Lawrence Y. Lin	Executive VP & CFO
Mr. Michael Paulo	VP, Chief Information & Digital Officer
Ms. Yvonne Perron	Vice President of Financial Planning & Analysis and Investor Relations
Mr. Ephraim Starr	Senior VP, General Counsel & Corporate Secretary
Ms. Olga Pirogova	Senior VP & Chief HR Officer
Mr. J. Robert Woodward	Senior VP of Global Quality & Engineering
Mr. Luc Provost	VP & CEO of B Medical Systems
Dr. Andrea O'Hara Ph.D.	Strategic Technical Specialist of Azenta Life Sciences

Important FAQs about investing in AZTA Stock from India :

What is Azenta share price today?

Azenta share price today is $29.83 as on August 20, 2025 at 11:43 PM IST. Azenta share today touched a day high of $29.83 and a low of $29.43.

What is the 52 week high and 52 week low for Azenta share?

Azenta share touched a 52 week high of $55.64 and a 52 week low of $23.91. Azenta stock price today i.e. August 20, 2025 at 11:43 PM IST is trending at $29.83, lower by 46.38% versus the 52 week high.

How to invest in Azenta Stock (AZTA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Azenta on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Azenta Shares that will get you 0.0503 shares as per Azenta share price of $29.83 per share as on August 20, 2025 at 11:43 PM IST.

What is the minimum amount required to buy Azenta Stock (AZTA) from India?

Indian investors can start investing in Azenta (AZTA) shares with as little as ₹87.0225 or $1 (as of August 20, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹870.22 in Azenta stock (as per the Rupee-Dollar exchange rate as on August 20, 2025). Based on Azenta share’s latest price of $29.83 as on August 20, 2025 at 11:43 PM IST, you will get 0.3352 shares of Azenta. Learn more about fractional shares .

What are the returns that Azenta has given to Indian investors in the last 5 years?

Azenta stock has given -69.7% share price returns and 16.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?